Cargando…
The Circulating CTRP13 in Type 2 Diabetes and Non-Alcoholic Fatty Liver Patients
Numerous studies have shown that C1q/TNF-related proteins (CTRPs) are involved in the pathophysiology of metabolic disorders, such as Non-alcoholic fatty liver disease (NAFLD) and Type 2 Diabetes (T2DM). There is a little information concerning CTRP13 in the context of NAFLD and T2DM. We evaluated t...
Autores principales: | Shanaki, Mehrnoosh, Fadaei, Reza, Moradi, Nariman, Emamgholipour, Solaleh, Poustchi, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148106/ https://www.ncbi.nlm.nih.gov/pubmed/27936230 http://dx.doi.org/10.1371/journal.pone.0168082 |
Ejemplares similares
-
The association of circulating levels of complement-C1q TNF-related protein 5 (CTRP5) with nonalcoholic fatty liver disease and type 2 diabetes: a case–control study
por: Emamgholipour, Solaleh, et al.
Publicado: (2015) -
The circulating levels of CTRP1 and CTRP5 are associated with obesity indices and carotid intima-media thickness (cIMT) value in patients with type 2 diabetes: a preliminary study
por: Majidi, Ziba, et al.
Publicado: (2021) -
Lower circulating levels of CTRP12 and CTRP13 in polycystic ovarian syndrome: Irrespective of obesity
por: Shanaki, Mehrnoosh, et al.
Publicado: (2018) -
Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery disease
por: Moradi, Nariman, et al.
Publicado: (2018) -
Circulating Level of CTRP1 in Patients with Nonalcoholic Fatty Liver Disease (NAFLD): Is It through Insulin Resistance?
por: Shabani, Parisa, et al.
Publicado: (2015)